Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients

(2015) Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients. International Journal of Diabetes in Developing Countries. pp. 630-631. ISSN 0973-3930

Full text not available from this repository.

Abstract

Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients

Item Type: Article
Keywords: Pharmacogenetic association of KCNJ11 (E23K) variant with therapeutic response to sulphonylurea (glibenclamide) in Iranian patients
Page Range: pp. 630-631
Journal or Publication Title: International Journal of Diabetes in Developing Countries
Journal Index: ISI
Volume: 35
Number: 4
Identification Number: https://doi.org/10.1007/s13410-015-0316-1
ISSN: 0973-3930
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/4523

Actions (login required)

View Item View Item